Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Change in number of shares and votes in Alligator Bioscience AB

During December 2021, the number of shares and votes in Alligator Bioscience AB (“Alligator”) has increased as a result of the completion of the rights issue of shares which was resolved by the Board of Directors on 7 October 2021 and approved by the Extraordinary General Meeting held on 8 November 2021, as well as the directed issue of shares to guarantors in the rights issue which was resolved by the Board of Directors on 2 December 2021. Per 30 December 2021, the number of registered shares and votes in Alligator amounts to 220,584,878. For more information, please contact: Julie

Viking Line Abp: Managers' Transactions

Viking Line Abp MANAGERS' TRANSACTIONS 30.12.2021, 11:15 AMManagers' transactionsViking Line Abp has on the 28th of December 2021 received the following notification pursuant to Article 19 of the EU Market Abuse Regulation from a person discharging managerial responsibilities in Viking Line Abp. Viking Line Abp - Managers' Transactions ____________________________________________Person subject to the notification requirementName: Peter WiklöfPosition: Member of the Board/Deputy member Issuer: Viking Line AbpLEI: 743700CUWGW42AGIDN49Notification type: INITIAL

Viking Line Abp: Managers' Transactions

Viking Line Abp MANAGERS' TRANSACTIONS 30.12.2021, 11:10 AMManagers' transactionsViking Line Abp has on the 28th of December 2021 received the following notification pursuant to Article 19 of the EU Market Abuse Regulation from a person discharging managerial responsibilities in Viking Line Abp.  Viking Line Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Christina  DahlblomPosition: Member of the Board/Deputy member Issuer: Viking Line AbpLEI: 743700CUWGW42AGIDN49Notification type: INITIAL

Change in the number of shares and votes in Endomines

Change in the number of shares and votes in Endomines Endomines AB, Stock Exchange Release 30 December 2021 at 10:00 CET   The total number of shares and votes in Endomines AB (publ) ("Endomines" or the "Company") as of 30 December 2021 amounts to 225,793,946.   The number of shares and votes in the Company has increased by 2,673,911 during December following the directed new issue of shares made under Endomines’ financing arrangement with LDA Capital. Following the above-mentioned share issue, Endomines share capital amounts to SEK 451,587,892.   Contact person

Number of shares and votes in Medicover

The number of votes in Medicover AB (publ) (“Medicover”) has changed as a result of conversions of in total 948,250 class A shares into B shares carried out in December following requests from shareholders in accordance with the conversion clause in Medicover’s articles of association. Today, the last trading day of the month, there are in total 151,935,195 shares in Medicover, of which 77,569,276 are class A shares, together carrying 77,569,276 votes, 70,781,275 are class B shares, together carrying 7,078,127.5 votes and 3,584,644 are class C shares, together carrying 358,464.4 votes.

Viking Line Abp: Managers' Transactions

Viking Line Abp MANAGERS' TRANSACTIONS 30.12.2021, 11:00 AMManagers' transactionsViking Line Abp has on the 28th of December 2021 received the following notification pursuant to Article 19 of the EU Market Abuse Regulation from a person discharging managerial responsibilities in Viking Line Abp.  Viking Line Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Jan  HansesPosition: Chief Executive Officer Issuer: Viking Line AbpLEI: 743700CUWGW42AGIDN49Notification type: INITIAL NOTIFICATIONReference

Viking Line Abp: Managers' Transactions

Viking Line Abp MANAGERS' TRANSACTIONS 30.12.2021, 10:50 AMManagers' transactionsViking Line Abp has on the 28th of December 2021 received the following notification pursuant to Article 19 of the EU Market Abuse Regulation from a person discharging managerial responsibilities in Viking Line Abp. Viking Line Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Ben LundqvistPosition: Member of the Board/Deputy member Issuer: Viking Line AbpLEI: 743700CUWGW42AGIDN49Notification type: INITIAL NOTIFICATION

VibroSense Dynamics AB signs Registration Agreement with a large Chinese company group in medical healthcare

VibroSense Dynamics AB (VibroSense) has signed an agreement with Genertec Universal Medical Group (UMCARE), to apply for registration of VibroSense Meter® II in the Chinese market. UMCARE estimate that there is a good possibility to obtain a regulatory approval and product registration in China within 12-18 months.The signed registration agreement is part of a recently started collaboration between VibroSense and UMCARE, to market and sell VibroSense Meter® II (VSM II) in China. After approved registration by the Chinese National Medical Products Administration (NMPA), VibroSense will hold

Irisity delivers video analytics for major U.S. utility operator in the United States.

Irisity AB (publ) delivers advanced video analytics for a major utility operator in the United States, with an estimated initial order value of USD 650,000. The contract includes licenses.  Due to the confidential nature of the security assets and relationship with the customer, we are unable to disclose any further details regarding its identity or nature of the project. For further information: Andreas Höye, Irisity IR Phone: +46 769 01 34 51 E-mail: andreas.hoye@irisity.com

Vestas wins EnVentus repowering order in Germany

News release from Northern & Central EuropeHamburg, 30 December 2021 Vestas has secured a 42 MW order from Repowering Wöhrden Poolgesellschaft GmbH & Co KG and Windkraft Looft Persenweg GmbH & Co. KG, for the Wöhrden repowering project in Schleswig Holstein, Germany. Vestas will supply, install and service seven V162-6.0 MW turbines, replacing the 25 legacy turbines currently powering the site, which will increase the energy output and extend the lifetime of the project site with Vestas’ best-in-class EnVentus platform while reducing the number of turbines on site. The repowering

Keliber Receives from Business Finland EUR 7 Million Grant for Sustainable Solutions

Business Finland has granted Keliber Technology Oy investment funding of a maximum of EUR 7 million. The funds are designated for the acquisition of technology that significantly improves environmental protection in lithium hydroxide production and also enables the utilisation of a side stream from production. Keliber plans to build its lithium chemical plant at Kokkola Industrial Park, and the production process will be based on novel soda leaching technology. In comparison with an alternative production process, soda leaching saves energy and promotes the circular economy. The

Viking Line Abp: Managers' Transactions

Viking Line Abp MANAGERS' TRANSACTIONS 30.12.2021, 9.40 AMManagers' transactionsViking Line Abp has on December 29, 2021 received the following notification pursuant to Article 19 of the EU Market Abuse Regulation from a person closely associated with a person discharging managerial responsibilities in Viking Line Abp.Viking Line Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Maelir ABPosition: Closely associated person (X) Legal person  (1):Person Discharging Managerial Responsibilities In Issuer

Comment from the Veg of Lund Nomination Committee

The Board of Directors of Veg of Lund has today convened an Extraordinary General Meeting to elect two new Board members. The nomination committee has proposed two persons, Håkan K Pålsson and Magnus Nordin, both with extensive experience in launching and selling fast-moving consumer products.The Board of Directors of Veg of Lund AB (publ) has today convened an Extraordinary General Meeting to elect two new Board members. The nomination committee’s proposal is based on the fact that the company now is ready for a more intensive marketing and sales phase, and that the board will be a

Notice of Extraordinary General Meeting of Veg of Lund AB (publ) for the election of new Board members

The shareholders of Veg of Lund AB (publ), reg. no 559054-4655, are convened to an Extraordinary General Meeting on Tuesday 18 January 2022 at 3:00 p.m. CET at the company’s premises at Stortorget 11 in Malmö, Sweden. Voting registration will begin at 2.30 p.m. CET. The venue for the meeting will be adapted to the current restrictions applicable to Covid-19. However, the Board of Directors urges caution and, if symptoms arise, to vote by proxy or to refrain from attending.Right to participateShareholders wishing to attend the Extraordinary General Meeting must be registered in the share

Investment AB Latour announces change of the total number of votes

After conversions of 5,200 shares from series A to series B in accordance with the company's Articles of Association, Investment AB Latour confirms the following. As per 30 December 2021 the company's share capital amounts unchanged to SEK 133,300,000. The total number of shares of series A amounts to 47,629,848 shares and shares of series B to 592,210,152. The number of votes in the company amounts to 1,068,508,632. Göteborg, December 30, 2021 INVESTMENT AB LATOUR (PUBL)Johan HjertonssonPresident and CEO For further information, please contact:Johan Hjertonsson, President

Office lets of 11,000 square meters

During the final quarter this year, Wallenstam has so far let office premises of almost 11,000 square meters in total in the Gothenburg region. The larger lets include office premises at attractive addresses in the middle of central Gothenburg such as Kungsportsavenyen and Storgatan. Other popular areas are Gårda, central Mölnlycke and Kallebäcks Terrasser.Lawyers, research companies, doctor's surgeries, companies in the flame combustion segment, and leading experts in bio convergence are some examples of Wallenstam’s new and new-old office tenants.   “Attractive office premises in

Episurf Medical submits 510(k) application for Episealer® Patellofemoral System

Episurf Medical (NASDAQ: EPIS B) today announces that the company is now filing a 510(k) application to the US FDA for US market clearance for the Episealer® Patellofemoral System. The application is ready for filing and following certain administrative steps, it is expected that it is submitted within the next days. The application will undergo a review process.  Episealer® Patellofemoral System is an implant system with two implants for treatment of chondral and osteochondral lesions in the knee joint. The system is based on Episurf Medical’s proprietary implant technology with

Curasight attends the J.P. Morgan Healthcare Conference and presents at HC Andersen Capital

Curasight A/S (“Curasight” or the “Company”) CEO Ulrich Krasilnikoff and CSO professor Andreas Kjær has been invited to J.P. Morgan 40[th] Annual Healthcare Conference which will take place 10-13 January 2022. Furthermore, Curasight will present a Deep Dive event in Brain cancer at HC Andersen Capital, 19 January 2022.The presentation at HC Andersen Capital will be webcasted live 11:00 - 11:30 (CET), Wednesday 19 January 2022. For more information – please click here  The presentation will be in English.

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 29th December 2021, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 26,784,714 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

DanCann Pharma A/S: Germanys intention to legalize cannabis is a gamechanger for Europe

COPENHAGEN, Denmark, 30 December 2021 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby communicate and comment on the intention from the new government of Germany to legalize controlled sales of cannabis for adults for recreational purposes. The German government estimates that the state can earn 4.7 billion euros (approximately DKK 35 billion) annually on a legalization.The value of the global illegal cannabis market is estimated by Fortune Business to be worth at least the equivalent of DKK 130 billion. The German

MapsPeople A/S: Company announcement - MapsPeople signs 4-year extension with NetDesign

MapsPeople A/S | MapsPeople signs 4-year extension with NetDesign regarding maps and geodata MAY NOT BE PUBLISHED, DISTRIBUTED, OR SUPPLIED OR IN PARTICULAR, DIRECTLY OR INDIRECTLY, IN OR TO THE USA, AUSTRALIA, CANADA, OR JAPAN.Company Announcement No. 16 - 2021 Aalborg, December 30[th], 2021 MapsPeople signs 4-year agreement with NetDesign regarding maps and geodata MapsPeople today announces a 4-year extension with NetDesign regarding maps and geodata included as a subcontract to one of NetDesign's major public customers. This agreement secures the majority of the budget

Oterra set to be un-beet-able after closing its latest acquisition

Oterra™, the world’s leading supplier of natural colors with the widest portfolio in the industry is pleased to announce the acquisition of Diana Food’s natural food coloring business was completed on the 29[th] December 2021.Oterra first announced its intent to acquire this segment of Diana Food back in September.Oterra will now begin the work of fully integrating Diana Food’s natural food coloring business into its portfolio as soon as possible. The acquisition, the second in six months since Oterra became a standalone company, further boosts its global footprint, with the addition of

Increase of the number of shares and votes in Hansa Biopharma AB

Lund, Sweden, December 30, 2021. Hansa Biopharma AB “Hansa” or “the Company”, (Nasdaq Stockholm: HNSA), the pioneer enzyme technology for rare immunological conditions, today announces that the Company’s registered share capital and number of outstanding shares and votes have increased during the month of December 2021. As previously announced on 12 December 2021, Hansa Biopharma’s board of directors resolved to issue 440,452 class C shares, by virtue of the authorization by the annual general meeting held on 12 May 2021. The class C shares do not entitle to dividends and each share

There are no items matching the current filter
There are no more items matching the current filter
Back to top